Sofinnova Ventures is a leading venture capital firm based in Menlo Park, CA, specializing in funding transformative biotech companies from inception to reality. With a focus on drug development, regulatory processes, company building, and IPOs, Sofinnova serves as a collaborative and experienced partner through every phase of growth.
Deploying human and financial capital at the intersection of life science, finance, and innovation, Sofinnova has a track record of funding tomorrow's cures. With a portfolio of over 110 companies, including 52 IPOs and 27 FDA-approved drugs, Sofinnova is dedicated to binding science innovation and advancing medical care to improve lives.
Generated from the website